$MYOS biotherapeutics and bionutrition company foc
Post# of 25331
Posted On: 05/28/2015 12:48:27 PM
$MYOS biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve human muscle health and performance, announced today that Health Canada, has reviewed and approved Fortetropin®, the Company's proprietary ingredient, for sale in powder dose form in Canada. Fortetropin is the first fertilized egg yolk powder ingredient to be approved by Health Canada and issued a Natural Product Number.
In order to support the incorporation of Fortetropin as a medicinal ingredient in finished products for sale in Canada, MYOS submitted evidence to the Natural and Non-prescription Health Products Directorate of Health Canada to substantiate the quality, safety and efficacy of Fortetropin. For more information about Fortetropin, a letter of access, explaining Fortetropin's claims and uses, is available upon request.
Maghsoud Dariani, head of Science and Technology for MYOS, commented, "Our investment in, and commitment to, Fortetropin runs deep. MYOS realized the potential of this ingredient in 2011, and invested a great deal of research into manufacturing, quality control and quality assurance. Fortetropin is a bioactive proteo-lipid complex made from fertilized chicken egg yolk using a proprietary process that retains the biological integrity and bioactivity of the mixture. Egg yolk is known as one of the most nutritionally dense natural foods available, making it a strong candidate for inclusion in medical and functional foods. MYOS is very excited to have the opportunity to sell Fortetropin powder in Canada."
http://www.otcmarkets.com/stock/MYOS/news
In order to support the incorporation of Fortetropin as a medicinal ingredient in finished products for sale in Canada, MYOS submitted evidence to the Natural and Non-prescription Health Products Directorate of Health Canada to substantiate the quality, safety and efficacy of Fortetropin. For more information about Fortetropin, a letter of access, explaining Fortetropin's claims and uses, is available upon request.
Maghsoud Dariani, head of Science and Technology for MYOS, commented, "Our investment in, and commitment to, Fortetropin runs deep. MYOS realized the potential of this ingredient in 2011, and invested a great deal of research into manufacturing, quality control and quality assurance. Fortetropin is a bioactive proteo-lipid complex made from fertilized chicken egg yolk using a proprietary process that retains the biological integrity and bioactivity of the mixture. Egg yolk is known as one of the most nutritionally dense natural foods available, making it a strong candidate for inclusion in medical and functional foods. MYOS is very excited to have the opportunity to sell Fortetropin powder in Canada."
http://www.otcmarkets.com/stock/MYOS/news
(0)
(0)Scroll down for more posts ▼